Clinical Trial Update: A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study update assessing the safety and tolerability of GA in patients with refractory neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• GA

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Pain, Intractable | EARLY_Phase 1 | Status: RECRUITING